About
Modified Protein for Treatment of Autoimmune Diseases
Symbol Therapeutics is a drug discovery company developing a novel immunoregulatory therapeutic protein, which is a modified form of the endogenous Semaphorin3A, for the treatment of systemic lupus erythematosus and other autoimmune diseases. Its proprietary modified protein is able to activate anti-inflammatory regulatory mechanisms and thereby restore normal immune homeostasis.
Identity
| Name | Symbol Therapeutics |
|---|---|
| Slug | symbol-therapeutics |
| Type / kind | startup |
| Source _id | fu28G8iupXNtPfYur9rnvHRSjnN4pQkfOnHNPu9GUWsPiFWKueCw7m |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Nov 2025 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Ness Ziona |
| HQ address | Ness Ziona, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
proteinsdrug-discoverypharmaceuticalstreatments
Funding
| Total raised | $3.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}